Related Experiment Video

Updated: Jan 2, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertension

Natalia Esquivel Garzón1, Luz Patricia Díaz Heredia2

  • 1Universidad Nacional de Colombia, Colombia, nesquivelg@unal.edu.co.

Investigacion Y Educacion En Enfermeria
|December 13, 2019
PubMed

Insights

The Spanish version of the Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH) is a valid and reliable tool. This validated scale accurately measures treatment adherence in hypertensive patients.

Area of Science:

  • Clinical Medicine
  • Psychometrics
  • Public Health

Background:

  • Hypertension management requires accurate assessment of patient adherence to treatment.
  • Existing adherence questionnaires may not be culturally or linguistically validated for Spanish-speaking populations.
  • The Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH) was developed to address this need.

Purpose of the Study:

  • To determine the validity and reliability of the Spanish version of the Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH).
  • To establish the psychometric properties of the TAQPH for use in Spanish-speaking hypertensive patients.

Main Methods:

  • A cross-sectional study was conducted in Ibagué, Colombia, with 220 patients diagnosed with primary hypertension.
  • Validity was assessed through face, content, and construct evaluation.
  • Reliability was determined using Cronbach's alpha and Fleiss' Kappa Coefficient.

Main Results:

  • Face validity showed substantial agreement (Kappa: 0.68-0.76).
  • Content validity index was satisfactory (0.91).
  • Exploratory factor analysis identified six factors explaining 54% of the variance; Cronbach's alpha for the total scale was 0.74.

Conclusions:

  • The Spanish version of the TAQPH is a valid and reliable instrument.
  • The TAQPH can be effectively used to evaluate treatment adherence in patients with primary hypertension in Spanish-speaking contexts.
Abstract

Keywords:
essential hypertensionpsychometricssurveys and questionnairestreatment adherence and compliancevalidation studies

Related Concept Videos

Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
713
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
400
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
309
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
521